id	sid	eid	entity	type
ijpds-4638	1	1	dyade et al	PERSON
ijpds-4638	1	2	cilnidipine online	PERSON
ijpds-4638	1	3	first	ORDINAL
ijpds-4638	1	4	indian	NORP
ijpds-4638	1	5	j pharm drug	ORG
ijpds-4638	1	6	1	CARDINAL
ijpds-4638	1	7	g. k.	PERSON
ijpds-4638	2	1	r. b. jadhav2	PERSON
ijpds-4638	2	2	repal3	GPE
ijpds-4638	2	3	uparwad3	PERSON
ijpds-4638	2	4	prashant suryawanshi3	PERSON
ijpds-4638	2	5	khapne3	ORG
ijpds-4638	2	6	shweta kokare3	PERSON
ijpds-4638	2	7	dnyaneshwar3	PERSON
ijpds-4638	2	8	1asso	CARDINAL
ijpds-4638	2	9	2principal	PERSON
ijpds-4638	2	10	3	CARDINAL
ijpds-4638	2	11	m. pharma	PERSON
ijpds-4638	2	12	bkii)-413115	ORG
ijpds-4638	2	13	baramati	GPE
ijpds-4638	2	14	dist pune	PERSON
ijpds-4638	2	15	maharashtra	GPE
ijpds-4638	2	16	india	GPE
ijpds-4638	4	1	usfda	ORG
ijpds-4638	6	1	50 %	PERCENT
ijpds-4638	7	1	221	CARDINAL
ijpds-4638	7	2	242	CARDINAL
ijpds-4638	8	1	2	CARDINAL
ijpds-4638	9	1	1-36	CARDINAL
ijpds-4638	9	2	1-16 μg	CARDINAL
ijpds-4638	10	1	103.773 %	PERCENT
ijpds-4638	10	2	96.825 %	PERCENT
ijpds-4638	10	3	2.04859	CARDINAL
ijpds-4638	10	4	1.26321	CARDINAL
ijpds-4638	11	1	0.58894	CARDINAL
ijpds-4638	11	2	1.15116	CARDINAL
ijpds-4638	13	1	1	CARDINAL
ijpds-4638	13	2	4	CARDINAL
ijpds-4638	13	3	2	CARDINAL
ijpds-4638	13	4	2e)-3	CARDINAL
ijpds-4638	13	5	1	CARDINAL
ijpds-4638	13	6	2	CARDINAL
ijpds-4638	13	7	3	CARDINAL
ijpds-4638	14	1	4	CARDINAL
ijpds-4638	14	2	5	CARDINAL
ijpds-4638	14	3	6	CARDINAL
ijpds-4638	14	4	8	CARDINAL
ijpds-4638	14	5	9-12	CARDINAL
ijpds-4638	15	1	2	CARDINAL
ijpds-4638	16	1	20th	ORDINAL
ijpds-4638	16	2	2024	CARDINAL
ijpds-4638	16	3	13th june 2024	DATE
ijpds-4638	16	4	15th	ORDINAL
ijpds-4638	16	5	lamino)-3-[p-(2methoxyethyl	ORG
ijpds-4638	17	1	1	CARDINAL
ijpds-4638	18	1	13	CARDINAL
ijpds-4638	18	2	17-22	CARDINAL
ijpds-4638	18	3	23	CARDINAL
ijpds-4638	18	4	24	CARDINAL
ijpds-4638	18	5	25	CARDINAL
ijpds-4638	18	6	31	CARDINAL
ijpds-4638	18	7	32	CARDINAL
ijpds-4638	18	8	33	CARDINAL
ijpds-4638	19	1	34	CARDINAL
ijpds-4638	20	1	cilnidipine	PERSON
ijpds-4638	20	2	indian	NORP
ijpds-4638	20	3	35	CARDINAL
ijpds-4638	21	1	36	CARDINAL
ijpds-4638	73	1	g. k. dyade	PERSON
ijpds-4638	73	2	bkii)-413115	ORG
ijpds-4638	73	3	baramati	GPE
ijpds-4638	73	4	dist pune	PERSON
ijpds-4638	73	5	maharashtra	GPE
ijpds-4638	73	6	india	GPE
ijpds-4638	76	1	dyade et al	PERSON
ijpds-4638	76	2	cilnidipine online	PERSON
ijpds-4638	76	3	first	ORDINAL
ijpds-4638	76	4	indian	NORP
ijpds-4638	76	5	j pharm drug	ORG
ijpds-4638	76	6	2	CARDINAL
ijpds-4638	77	1	3739	CARDINAL
ijpds-4638	77	2	2	CARDINAL
ijpds-4638	77	3	ich guidelines q8 (	ORG
ijpds-4638	78	1	40	CARDINAL
ijpds-4638	82	1	2	CARDINAL
ijpds-4638	82	2	41	CARDINAL
ijpds-4638	85	1	first	ORDINAL
ijpds-4638	86	1	atp defines	PERSON
ijpds-4638	86	2	42	CARDINAL
ijpds-4638	89	1	1900i	DATE
ijpds-4638	89	2	1700	CARDINAL
ijpds-4638	89	3	kyoto	GPE
ijpds-4638	89	4	japan	GPE
ijpds-4638	89	5	2	CARDINAL
ijpds-4638	89	6	± 1	CARDINAL
ijpds-4638	89	7	10 mm	QUANTITY
ijpds-4638	90	1	bombay	GPE
ijpds-4638	90	2	burmah trading corpo ltd	ORG
ijpds-4638	91	1	200a	CARDINAL
ijpds-4638	91	2	1.8 ltr	QUANTITY
ijpds-4638	92	1	macleods pharmaceuticals ltd	ORG
ijpds-4638	92	2	mumbai	GPE
ijpds-4638	92	3	cil from swapnroop	ORG
ijpds-4638	92	4	aurangabad	ORG
ijpds-4638	92	5	maharashtra	GPE
ijpds-4638	92	6	india	GPE
ijpds-4638	92	7	10	CARDINAL
ijpds-4638	95	1	90%	PERCENT
ijpds-4638	95	2	0.1 n hcl	QUANTITY
ijpds-4638	95	3	0.1 n	QUANTITY
ijpds-4638	95	4	0.1 n	QUANTITY
ijpds-4638	96	1	90%	PERCENT
ijpds-4638	97	1	400	CARDINAL
ijpds-4638	97	2	200	CARDINAL
ijpds-4638	98	1	cilnidipine online	PERSON
ijpds-4638	98	2	first	ORDINAL
ijpds-4638	98	3	indian	NORP
ijpds-4638	98	4	j pharm drug	ORG
ijpds-4638	98	5	3	CARDINAL
ijpds-4638	98	6	90%	PERCENT
ijpds-4638	99	1	3	CARDINAL
ijpds-4638	99	2	10 mg	QUANTITY
ijpds-4638	99	3	25 ml	QUANTITY
ijpds-4638	100	1	90%	PERCENT
ijpds-4638	100	2	25 ml	QUANTITY
ijpds-4638	101	1	10 ml	QUANTITY
ijpds-4638	101	2	50%	PERCENT
ijpds-4638	101	3	10 ml	QUANTITY
ijpds-4638	102	1	cil	ORG
ijpds-4638	102	2	242	CARDINAL
ijpds-4638	102	3	221	CARDINAL
ijpds-4638	102	4	cil	ORG
ijpds-4638	104	1	1 to 16 μg	CARDINAL
ijpds-4638	104	2	1 to 36μg	CARDINAL
ijpds-4638	108	1	221	CARDINAL
ijpds-4638	108	2	cil	ORG
ijpds-4638	108	3	242	CARDINAL
ijpds-4638	109	1	242	CARDINAL
ijpds-4638	109	2	cil	ORG
ijpds-4638	109	3	two	CARDINAL
ijpds-4638	109	4	221	CARDINAL
ijpds-4638	109	5	242	CARDINAL
ijpds-4638	109	6	1 and 2	CARDINAL
ijpds-4638	110	1	abc	ORG
ijpds-4638	111	1	28	CARDINAL
ijpds-4638	112	1	mps	PERSON
ijpds-4638	112	2	1	CARDINAL
ijpds-4638	112	3	2	CARDINAL
ijpds-4638	112	4	1	CARDINAL
ijpds-4638	112	5	2	CARDINAL
ijpds-4638	112	6	ax2 = absorptivity	ORG
ijpds-4638	112	7	1	CARDINAL
ijpds-4638	112	8	2	CARDINAL
ijpds-4638	112	9	2	CARDINAL
ijpds-4638	112	10	zero	CARDINAL
ijpds-4638	112	11	first	ORDINAL
ijpds-4638	112	12	second	ORDINAL
ijpds-4638	114	1	zero	CARDINAL
ijpds-4638	114	2	zero	CARDINAL
ijpds-4638	114	3	one	CARDINAL
ijpds-4638	115	1	16	CARDINAL
ijpds-4638	115	2	10 ml	QUANTITY
ijpds-4638	115	3	400	CARDINAL
ijpds-4638	115	4	200	CARDINAL
ijpds-4638	115	5	50%	PERCENT
ijpds-4638	117	1	221	CARDINAL
ijpds-4638	117	2	242	CARDINAL
ijpds-4638	118	1	dyade et al	PERSON
ijpds-4638	118	2	cilnidipine online	PERSON
ijpds-4638	118	3	first	ORDINAL
ijpds-4638	118	4	indian	NORP
ijpds-4638	118	5	j pharm drug	ORG
ijpds-4638	118	6	4 zero	CARDINAL
ijpds-4638	118	7	first	ORDINAL
ijpds-4638	119	1	zero	CARDINAL
ijpds-4638	119	2	263	CARDINAL
ijpds-4638	119	3	cil	ORG
ijpds-4638	119	4	229.5	CARDINAL
ijpds-4638	119	5	zero	CARDINAL
ijpds-4638	120	1	first	ORDINAL
ijpds-4638	121	1	fig 4	ORG
ijpds-4638	125	1	six	CARDINAL
ijpds-4638	128	1	1-36μg	CARDINAL
ijpds-4638	128	2	1-16 μg	CARDINAL
ijpds-4638	128	3	400	CARDINAL
ijpds-4638	128	4	200	CARDINAL
ijpds-4638	128	5	221	CARDINAL
ijpds-4638	128	6	242	CARDINAL
ijpds-4638	129	1	microsoft	ORG
ijpds-4638	131	1	12.5 mg	QUANTITY
ijpds-4638	131	2	2.5 mg cil	QUANTITY
ijpds-4638	131	3	25 ml	QUANTITY
ijpds-4638	132	1	90%	PERCENT
ijpds-4638	132	2	10 mins	TIME
ijpds-4638	132	3	25 ml	QUANTITY
ijpds-4638	133	1	50%	PERCENT
ijpds-4638	134	1	400	CARDINAL
ijpds-4638	134	2	200	CARDINAL
ijpds-4638	134	3	221	CARDINAL
ijpds-4638	134	4	242	CARDINAL
ijpds-4638	135	1	first	ORDINAL
ijpds-4638	135	2	229.5	CARDINAL
ijpds-4638	135	3	263	CARDINAL
ijpds-4638	138	1	100 %	PERCENT
ijpds-4638	139	1	three	CARDINAL
ijpds-4638	140	1	six	CARDINAL
ijpds-4638	140	2	inter day	DATE
ijpds-4638	141	1	loq	ORG
ijpds-4638	141	2	loq	ORG
ijpds-4638	141	3	10 σ	QUANTITY
ijpds-4638	141	4	loq	ORG
ijpds-4638	141	5	σ	ORG
ijpds-4638	147	1	two	CARDINAL
ijpds-4638	147	2	221	CARDINAL
ijpds-4638	148	1	cilnidipine online	PERSON
ijpds-4638	148	2	first	ORDINAL
ijpds-4638	148	3	indian	NORP
ijpds-4638	148	4	j pharm drug	ORG
ijpds-4638	148	5	5	CARDINAL
ijpds-4638	148	6	242	CARDINAL
ijpds-4638	149	1	5	CARDINAL
ijpds-4638	149	2	six	CARDINAL
ijpds-4638	151	1	1 16μg	CARDINAL
ijpds-4638	151	2	0.5157 8 μg	QUANTITY
ijpds-4638	151	3	0.004676	CARDINAL
ijpds-4638	152	1	six	CARDINAL
ijpds-4638	152	2	1-36	CARDINAL
ijpds-4638	152	3	1-16 μg	CARDINAL
ijpds-4638	152	4	first	ORDINAL
ijpds-4638	158	1	6	CARDINAL
ijpds-4638	158	2	cil fig	ORG
ijpds-4638	158	3	first	ORDINAL
ijpds-4638	159	1	intraday	TIME
ijpds-4638	160	1	loq	ORG
ijpds-4638	160	2	loq	ORG
ijpds-4638	162	1	cilnidipine online	PERSON
ijpds-4638	162	2	first	ORDINAL
ijpds-4638	162	3	indian	NORP
ijpds-4638	162	4	j pharm drug	ORG
ijpds-4638	162	5	6	CARDINAL
ijpds-4638	164	1	2	CARDINAL
ijpds-4638	164	2	microsoft	ORG
ijpds-4638	164	3	221	CARDINAL
ijpds-4638	164	4	229.5 263	CARDINAL
ijpds-4638	165	1	1–36 μg/ml	QUANTITY
ijpds-4638	165	2	0.9984 0.9994 0.9991	MONEY
ijpds-4638	170	1	0.0001	CARDINAL
ijpds-4638	170	2	3	CARDINAL
ijpds-4638	170	3	t 50 47.084	DATE
ijpds-4638	171	1	103.7 73	CARDINAL
ijpds-4638	171	2	ci l 10	ORG
ijpds-4638	172	1	4	CARDINAL
ijpds-4638	174	1	s.d.	PERSON
ijpds-4638	176	1	y precisi	PERSON
ijpds-4638	177	1	74	CARDINAL
ijpds-4638	177	2	accura cy	PERSON
ijpds-4638	177	3	100%	PERCENT
ijpds-4638	177	4	2.127 12	CARDINAL
ijpds-4638	177	5	cil 94.845 %	ORG
ijpds-4638	177	6	1.263 21	DATE
ijpds-4638	177	7	1.331 88	DATE
ijpds-4638	177	8	ii precisi	PERSON
ijpds-4638	177	9	y precisi	PERSON
ijpds-4638	177	10	102.06 6%	PERCENT
ijpds-4638	177	11	1.622 08	DATE
ijpds-4638	177	12	2.260 24	DATE
ijpds-4638	177	13	100%	PERCENT
ijpds-4638	177	14	97.646 %	PERCENT
ijpds-4638	177	15	1.159 71	DATE
ijpds-4638	177	16	cilnidipine online	PERSON
ijpds-4638	177	17	first	ORDINAL
ijpds-4638	177	18	indian	NORP
ijpds-4638	177	19	j pharm drug	ORG
ijpds-4638	177	20	7	CARDINAL
ijpds-4638	181	1	1	CARDINAL
ijpds-4638	182	1	merck	ORG
ijpds-4638	182	2	15th	ORDINAL
ijpds-4638	182	3	cambridge	GPE
ijpds-4638	182	4	uk	GPE
ijpds-4638	182	5	2013	DATE
ijpds-4638	182	6	406	CARDINAL
ijpds-4638	182	7	1011	CARDINAL
ijpds-4638	183	1	2	CARDINAL
ijpds-4638	183	2	alison brayfield	PERSON
ijpds-4638	183	3	martindale	ORG
ijpds-4638	183	4	39th	ORDINAL
ijpds-4638	183	5	london	GPE
ijpds-4638	183	6	2017	DATE
ijpds-4638	183	7	1264, 1306	DATE
ijpds-4638	184	1	3	CARDINAL
ijpds-4638	184	2	jadhav r s	PERSON
ijpds-4638	184	3	bharad j	PERSON
ijpds-4638	186	1	j. pharm	ORG
ijpds-4638	188	1	sci. 2018	ORG
ijpds-4638	188	2	8(3):187	CARDINAL
ijpds-4638	189	1	4	CARDINAL
ijpds-4638	190	1	der pharmacia lettre	PERSON
ijpds-4638	191	1	2015	DATE
ijpds-4638	191	2	7(7	CARDINAL
ijpds-4638	191	3	299	CARDINAL
ijpds-4638	192	1	5	CARDINAL
ijpds-4638	192	2	kadia	PERSON
ijpds-4638	192	3	dilip g m.	PERSON
ijpds-4638	194	1	j. pharm	ORG
ijpds-4638	195	1	pharm	ORG
ijpds-4638	196	1	sci	ORG
ijpds-4638	197	1	2014;6(6):401407	CARDINAL
ijpds-4638	197	2	6	CARDINAL
ijpds-4638	197	3	sankar p	PERSON
ijpds-4638	197	4	babu	PERSON
ijpds-4638	199	1	2019	CARDINAL
ijpds-4638	199	2	1886-1894	DATE
ijpds-4638	200	1	7	CARDINAL
ijpds-4638	200	2	tiwari	PERSON
ijpds-4638	200	3	shirsat m k	PERSON
ijpds-4638	200	4	kulkarni a.	PERSON
ijpds-4638	200	5	cilnidipine.	ORG
ijpds-4638	202	1	97-100	CARDINAL
ijpds-4638	203	1	8	CARDINAL
ijpds-4638	204	1	marques	PERSON
ijpds-4638	204	2	kumar	PERSON
ijpds-4638	204	3	microchemical journal	ORG
ijpds-4638	205	1	2023	CARDINAL
ijpds-4638	205	2	193	CARDINAL
ijpds-4638	205	3	doi.org/10.1016/j.microc.2023.109124.	CARDINAL
ijpds-4638	206	1	shah p	PERSON
ijpds-4638	206	2	dhaduk b. rp-hplc	PERSON
ijpds-4638	206	3	olmesartan medoxomil	GPE
ijpds-4638	208	1	2022	CARDINAL
ijpds-4638	208	2	629-641	CARDINAL
ijpds-4638	208	3	10	CARDINAL
ijpds-4638	208	4	sawaikar	NORP
ijpds-4638	208	5	kapupara p. development	ORG
ijpds-4638	210	1	2020	DATE
ijpds-4638	210	2	13(5):23762380	CARDINAL
ijpds-4638	210	3	11	CARDINAL
ijpds-4638	210	4	dagariya r k	PERSON
ijpds-4638	210	5	jat	ORG
ijpds-4638	210	6	irbesartan	ORG
ijpds-4638	211	1	journal of drug	ORG
ijpds-4638	212	1	2017	CARDINAL
ijpds-4638	212	2	7(4	CARDINAL
ijpds-4638	212	3	88-96	DATE
ijpds-4638	213	1	12	CARDINAL
ijpds-4638	214	1	pharmacia lett.	PERSON
ijpds-4638	215	1	2015;7(5):333-40	CARDINAL
ijpds-4638	215	2	13	CARDINAL
ijpds-4638	215	3	o, et.al	DATE
ijpds-4638	218	1	2023	CARDINAL
ijpds-4638	218	2	18(2):63-69	DATE
ijpds-4638	219	1	14	CARDINAL
ijpds-4638	220	1	biol sci	PERSON
ijpds-4638	220	2	2013	DATE
ijpds-4638	220	3	3(4	CARDINAL
ijpds-4638	220	4	224	CARDINAL
ijpds-4638	220	5	15 verma n	QUANTITY
ijpds-4638	224	1	2011	DATE
ijpds-4638	224	2	4(2):271-2	DATE
ijpds-4638	224	3	16	CARDINAL
ijpds-4638	225	1	chemtech	NORP
ijpds-4638	226	1	2009;1(4	DATE
ijpds-4638	226	2	1273-1277	DATE
ijpds-4638	227	1	17	CARDINAL
ijpds-4638	227	2	k h	ORG
ijpds-4638	227	3	soniwala m	ORG
ijpds-4638	228	1	journal of drug	ORG
ijpds-4638	229	1	2022	CARDINAL
ijpds-4638	230	1	12(3-s	CARDINAL
ijpds-4638	230	2	64	CARDINAL
ijpds-4638	230	3	18	CARDINAL
ijpds-4638	230	4	sindhusha m	ORG
ijpds-4638	230	5	soraj k	PERSON
ijpds-4638	231	1	third	ORDINAL
ijpds-4638	233	1	2020;12(5	CARDINAL
ijpds-4638	234	1	54	CARDINAL
ijpds-4638	234	2	19	CARDINAL
ijpds-4638	236	1	j. ana	PERSON
ijpds-4638	237	1	bio	PERSON
ijpds-4638	238	1	2013	DATE
ijpds-4638	238	2	3(3):82-85	DATE
ijpds-4638	238	3	20	CARDINAL
ijpds-4638	238	4	vora b n	PERSON
ijpds-4638	238	5	nayak p p	ORG
ijpds-4638	238	6	olmesartan medoxomil	GPE
ijpds-4638	240	1	2012	DATE
ijpds-4638	240	2	3(1	CARDINAL
ijpds-4638	240	3	44	CARDINAL
ijpds-4638	241	1	21	CARDINAL
ijpds-4638	241	2	olmesartan medoxomil	GPE
ijpds-4638	242	1	international journal of research	ORG
ijpds-4638	243	1	935	CARDINAL
ijpds-4638	244	1	22	CARDINAL
ijpds-4638	244	2	mashru	PERSON
ijpds-4638	246	1	2012	DATE
ijpds-4638	246	2	3(5	CARDINAL
ijpds-4638	246	3	1348-1354	DATE
ijpds-4638	247	1	23	CARDINAL
ijpds-4638	248	1	kumar j s	PERSON
ijpds-4638	248	2	piyush s	PERSON
ijpds-4638	250	1	2014	DATE
ijpds-4638	251	1	13(2	CARDINAL
ijpds-4638	251	2	50-56	CARDINAL
ijpds-4638	251	3	24	CARDINAL
ijpds-4638	251	4	verma a.	PERSON
ijpds-4638	252	1	cilnidipine online	PERSON
ijpds-4638	252	2	first	ORDINAL
ijpds-4638	252	3	indian	NORP
ijpds-4638	252	4	j pharm drug	ORG
ijpds-4638	252	5	8	CARDINAL
ijpds-4638	254	1	2021;14(2):931	CARDINAL
ijpds-4638	255	1	25	CARDINAL
ijpds-4638	255	2	singh	GPE
ijpds-4638	255	3	rajput	PERSON
ijpds-4638	255	4	carpenter g	PERSON
ijpds-4638	256	1	azelnidipine measurment	ORG
ijpds-4638	258	1	2023;14(3):1	CARDINAL
ijpds-4638	258	2	26	CARDINAL
ijpds-4638	258	3	s s.	PERSON
ijpds-4638	258	4	telmisartan	GPE
ijpds-4638	259	1	int j pharm sci & res	ORG
ijpds-4638	259	2	2021	CARDINAL
ijpds-4638	259	3	1651	CARDINAL
ijpds-4638	259	4	27	CARDINAL
ijpds-4638	259	5	manish	PERSON
ijpds-4638	259	6	varsha	PERSON
ijpds-4638	260	1	telmisartan	GPE
ijpds-4638	261	1	chemical & pharmaceutical analysis	ORG
ijpds-4638	261	2	2021	CARDINAL
ijpds-4638	261	3	8(4	CARDINAL
ijpds-4638	261	4	1-11	CARDINAL
ijpds-4638	262	1	28	CARDINAL
ijpds-4638	264	1	pharma science monitor	ORG
ijpds-4638	265	1	2018	DATE
ijpds-4638	265	2	9(2):205	CARDINAL
ijpds-4638	265	3	29	CARDINAL
ijpds-4638	266	1	jordan journal of pharmaceutical sciences	ORG
ijpds-4638	266	2	2016	CARDINAL
ijpds-4638	266	3	9(3):193	CARDINAL
ijpds-4638	266	4	30	CARDINAL
ijpds-4638	266	5	olmesartan medoxomil	GPE
ijpds-4638	268	1	2012	DATE
ijpds-4638	268	2	3(151):1-3	DATE
ijpds-4638	268	3	saravanan g	PERSON
ijpds-4638	271	1	j. pharm	ORG
ijpds-4638	272	1	pharm	ORG
ijpds-4638	273	1	sci	ORG
ijpds-4638	274	1	2015;7(1):150-4	CARDINAL
ijpds-4638	274	2	32	CARDINAL
ijpds-4638	274	3	kumar t h	PERSON
ijpds-4638	274	4	rasheed s h	ORG
ijpds-4638	276	1	2023;1(1):17-26	CARDINAL
ijpds-4638	277	1	33	CARDINAL
ijpds-4638	277	2	patel k	PERSON
ijpds-4638	277	3	macwan p	GPE
ijpds-4638	277	4	prajapati	PERSON
ijpds-4638	278	1	al	PERSON
ijpds-4638	279	1	jpc	ORG
ijpds-4638	279	2	tlc	PERSON
ijpds-4638	280	1	2023;36	CARDINAL
ijpds-4638	280	2	265-277	CARDINAL
ijpds-4638	281	1	34	CARDINAL
ijpds-4638	281	2	patil v	LAW
ijpds-4638	283	1	2012	DATE
ijpds-4638	284	1	1(1):1-5	DATE
ijpds-4638	284	2	35	CARDINAL
ijpds-4638	284	3	indian	NORP
ijpds-4638	284	4	govt of india	ORG
ijpds-4638	284	5	ministry of health	ORG
ijpds-4638	284	6	8th	ORDINAL
ijpds-4638	284	7	indian	NORP
ijpds-4638	284	8	ghaziabad	GPE
ijpds-4638	284	9	2018	DATE
ijpds-4638	284	10	1616	CARDINAL
ijpds-4638	284	11	2583	DATE
ijpds-4638	285	1	36	CARDINAL
ijpds-4638	285	2	british	NORP
ijpds-4638	285	3	london	GPE
ijpds-4638	285	4	2019	DATE
ijpds-4638	285	5	1361	CARDINAL
ijpds-4638	285	6	1762	DATE
ijpds-4638	286	1	37	CARDINAL
ijpds-4638	287	1	8	CARDINAL
ijpds-4638	288	1	4	CARDINAL
ijpds-4638	289	1	2009	DATE
ijpds-4638	290	1	1-28	CARDINAL
ijpds-4638	291	1	38	CARDINAL
ijpds-4638	292	1	9	CARDINAL
ijpds-4638	293	1	4	CARDINAL
ijpds-4638	293	2	2005	DATE
ijpds-4638	293	3	1-23	CARDINAL
ijpds-4638	293	4	39	CARDINAL
ijpds-4638	294	1	10	CARDINAL
ijpds-4638	295	1	4	CARDINAL
ijpds-4638	295	2	2008	DATE
ijpds-4638	295	3	1-21	CARDINAL
ijpds-4638	295	4	40	CARDINAL
ijpds-4638	296	1	2	CARDINAL
ijpds-4638	297	1	4	CARDINAL
ijpds-4638	297	2	1	CARDINAL
ijpds-4638	297	3	41 schweitzer m	QUANTITY
ijpds-4638	297	4	pohl m	PERSON
ijpds-4638	299	1	2010	DATE
ijpds-4638	299	2	34	CARDINAL
ijpds-4638	299	3	12-29	CARDINAL
ijpds-4638	300	1	42	CARDINAL
ijpds-4638	300	2	kord	PERSON
ijpds-4638	302	1	2011	DATE
ijpds-4638	303	1	100:797-812	CARDINAL
ijpds-4638	304	1	43	CARDINAL
ijpds-4638	305	1	2011	DATE
ijpds-4638	305	2	3):179-187	CARDINAL
ijpds-4638	306	1	dyade gk	PERSON
ijpds-4638	306	2	jadhav rb	PERSON
ijpds-4638	306	3	uparwad s	PERSON
ijpds-4638	306	4	kokare s	ORG
ijpds-4638	306	5	a. qbd	PERSON
ijpds-4638	307	1	indian	NORP
ijpds-4638	307	2	2024	CARDINAL
ijpds-4638	307	3	first	ORDINAL